NCT03700372View on ClinicalTrials.gov

IMPACT: A Safety and Feasibility Study of the IOWA Approach Cardiac Ablation System

CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

December 13, 2017

Primary Completion Date

April 9, 2019

Study Completion Date

March 3, 2021

Conditions
Paroxysmal Atrial Fibrillation
Interventions
DEVICE

IOWA Approach Cardiac Ablation System

Epicardial ablation using the IOWA Approach Cardiac Ablation System

Trial Locations (1)

33604

CHU Bordeaux, Pessac

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT03700372 - IMPACT: A Safety and Feasibility Study of the IOWA Approach Cardiac Ablation System | Biotech Hunter | Biotech Hunter